Previous Close | 234.33 |
Open | 243.00 |
Bid | 254.77 x 100 |
Ask | 255.21 x 100 |
Day's Range | 236.65 - 258.48 |
52 Week Range | 204.44 - 261.54 |
Volume | |
Avg. Volume | 499,663 |
Market Cap | 11.32B |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | 12.89 |
EPS (TTM) | 19.80 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 295.18 |
Explore key insights from UTHR's Q1 2024 earnings, featuring a 34% revenue surge and significant strides in product development and shareholder initiatives.
Insightful Analysis of United Therapeutics Corp's Financial Health and Market Position
Q1 2024 United Therapeutics Corp Earnings Call